Cargando…
Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment
OBJECTIVE: To calculate sustainable generic prices for 4 tyrosine kinase inhibitors (TKIs). BACKGROUND: TKIs have proven survival benefits in the treatment of several cancers, including chronic myeloid leukaemia, breast, liver, renal and lung cancer. However, current high prices are a barrier to tre...
Autores principales: | Hill, Andrew, Gotham, Dzintars, Fortunak, Joseph, Meldrum, Jonathan, Erbacher, Isabelle, Martin, Manuel, Shoman, Haitham, Levi, Jacob, Powderly, William G, Bower, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735306/ https://www.ncbi.nlm.nih.gov/pubmed/26817636 http://dx.doi.org/10.1136/bmjopen-2015-009586 |
Ejemplares similares
-
Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis
por: Hill, Andrew, et al.
Publicado: (2017) -
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
por: Hill, Andrew, et al.
Publicado: (2016) -
Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries
por: Hill, Andrew, et al.
Publicado: (2015) -
Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
por: Barber, Melissa J., et al.
Publicado: (2020) -
Production costs and potential prices for biosimilars of human insulin and insulin analogues
por: Gotham, Dzintars, et al.
Publicado: (2018)